Ribonoscopy and “Theragnostics”

Chapter

Abstract

The combined field of researches in drug therapy, diagnostics, and prognostics may be referred to as “theragnostics.” Some investigators have already coined the word “theranostics” to refer to the same but I prefer theragnostics over theranostics because the second stem in the latter word, “nostics,” has no etymological basis. The main purpose of this section is to propose that ribonoscopy will find important applications in theragnostics.

Keywords

Marketing Serine Doxorubicin Galactose Apixaban 

References

  1. Bain & Company: Cost of Developing a New Drug Increases to About 1.7 Billion, http://www.loyaltyrules.com/bainweb/publications/publications_detail.asp?id=14 245&menu_url=publications_results.asp (2007)
  2. Folgueira, M., Carraro, D., et al.: Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin. Cancer Res. 11(2), 7434–7442 (2005)CrossRefGoogle Scholar
  3. Ingleman-Sundberg, M.: Pharmacogenetics and Epigenetics of Drug Metabolism and Action, a lecture delivered at the conference entitled “Prospects for Individualized Drug Therapy: Person-to-Person Differences in Drug Metabolism and Disposition”, held at the Ernest Mario School of Pharmacy, Rutgers University, Piscataway, N.J, May 26 2010Google Scholar
  4. Perou, C.M., Sorlie, T., Eisen, M.B., et al.: Molecular portraits of human breast tumors. Nature 406(6797), 747–52 (2000)ADSCrossRefGoogle Scholar
  5. Schmucker, D., Clemens, J.C., Shu, H., Worby, C.A., Xiao, J., MUda, M.: Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101(6), 671–684 (2000)CrossRefGoogle Scholar
  6. Wikipedia: Theranostics, http://en.wikipedia.org/wiki/Theranostics (2010)

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Dept. of Pharmacol. & Toxicol. Ernest Mario School of PharmacyRutgers UniversityPiscatawayUSA

Personalised recommendations